RGT Wealth Advisors’s ATI Physical Therapy, Inc. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share ATIP.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-123
Closed 346
2021
Q4
$0 Buy
+123
New +$60 ﹤0.01% 347

Other funds holding ATIP.WS

RGT Wealth Advisors's ATIP.WS Position: Q1 2022 in Review

RGT Wealth Advisors sold out of ATI Physical Therapy, Inc. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share (ATIP.WS) in Q1 2022, closing a stake of 123 shares.

RGT Wealth Advisors first reported a position in ATIP.WS in Q4 2021 and held it in 1 quarter. The position peaked at $0 in Q4 2021. 18 funds tracked by Wall St. Rank hold ATIP.WS as of Q1 2022.

  • RGT Wealth Advisors reported no remaining ATI Physical Therapy, Inc. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share position as of Q1 2022 after selling out during the quarter.
  • RGT Wealth Advisors sold 123 ATI Physical Therapy, Inc. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share shares in Q1 2022.
  • RGT Wealth Advisors first reported a position in ATI Physical Therapy, Inc. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share in Q4 2021 and held it in 1 quarter.
  • RGT Wealth Advisors's ATI Physical Therapy, Inc. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share position peaked at $0 in Q4 2021.
  • 18 funds tracked by Wall St. Rank held ATI Physical Therapy, Inc. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share as of Q1 2022.

Based on RGT Wealth Advisors's 13F filing for Q1 2022, filed 5 May 2022.